Impact of dual therapy with metronidazole and ciprofloxacin VS Monotherapy with metronidazole in treating clostridium difficile infection: A six-month study  

Dr hina munawar, AJKMC Muzaffarbad

Dr haseeb Ahmed, Pmc rawalakot

Dr abid ali gorsi, Pmc rawalakot

ABSTRACT:  

Background: Clostridium difficile infection (CDI) has been classified as a major cause of hospital-acquired gastrointestinal disease resulting in prolonged hospitalization, recurrence of infections and additional morbidity. Even though a metronidazole therapy alone was widely used, new findings indicated that dual antibiotic therapy might enhance treatment response. The combination therapy of metronidazole and ciprofloxacin was offered to increase the effectiveness of microbial eradication and decrease the recurrence, yet the comparative results were not extensive. 

Purpose: The purpose of the research was to determine the clinical effectiveness of dual and monotherapy of metronidazole and ciprofloxacin in the treatment of CDI. 

Methods: The present paper was done in Allied hospital faisalabad, and the duration of the study was between October 2024 and March 2025. There were 90 CDI patients who were involved. The population was allocated into two groups; Group A which was metronidazole monotherapy and Group B was metronidazole and ciprofloxacin combination. Stool toxin assay and clinical manifestations were found to be typical of the diagnosis. The response to the treatment, the time of symptom resolution, the frequency of the recurrence, and the adverse drug reactions were investigated. Data analysis was performed through both descriptive and comparative statistics tests in order to establish the therapeutic difference amid the two treatment methods. 

Results: According to the results of the study, it was identified that the percentage of patients who improved on their clinical state with dual therapy was more pronounced than the percentage of patients improving with monotherapy. Diarrhea and abdominal discomfort were resolved faster in the dual therapy group. The number of cases of recurrence was also less in the combination group, and the length of stay was also reduced in the hospitals. The side effects were few and similar in the two groups in that the side effects showed improved clinical efficacy without reducing the safety. 

Conclusion: The research found out that metronidazole and ciprofloxacin had better therapeutic effects in CDI management than when the latter is administered in case of single therapy. The combination regimen resulted in a significant decrease in recurrence, an increase in symptom resolution, and an increase in the overall recovery. Thus, the implementation of dual therapy may be a better approach in enhancing the treatment results of CDI. 

Keywords: Clostridium difficile infection, metronidazole, ciprofloxacin, dual therapy, recurrence, treatment efficacy.